<DOC>
	<DOC>NCT01444586</DOC>
	<brief_summary>This is a local, prospective, multicenter, non-interventional, observational study. Primary objective is to describe how in "real life" thromboprophylaxis is carried out after the discharge from a hospital in the patients who undergo elective knee and hip replacement and who receive Xarelto during hospitalization.</brief_summary>
	<brief_title>Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)</brief_title>
	<detailed_description />
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Male and female patients â‰¥ 18 years old Elective hip or knee replacement Planned VTE prevention with Xarelto Written informed consent The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study. Contraindications for the use of Xarelto in accordance with the effective instruction Any reasons of medical and nonmedical character, which in the opinion of the physician can hamper participation of the patient in NIS, including a potentially low compliance, impossibility of making the final visit due to distant place of residence of the patient.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>non-interventional</keyword>
	<keyword>Xarelto</keyword>
	<keyword>knee replacement</keyword>
	<keyword>hip replecement</keyword>
	<keyword>Russia</keyword>
</DOC>